Inadequate storage of subcutaneous biological agents by patients with inflammatory bowel disease: Another factor driving loss of response?

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|33|1|10-11

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.33, Iss.1, 2018-01, pp. : 10-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Differential Behavior of Coagulation Factor XIII in Patients with Inflammatory Bowel Disease and in Patients with Giant Cell Arteritis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 6, 2000-06 ,pp. : 326-335

Karger

Access to resources Recommend Favorite

Frequency and Characteristics of Pancreatitis in Patients with Inflammatory Bowel Disease

By  

Pancreatology, Vol. 6, Iss. 5, 2006-10 ,pp. : 464-471

Karger

Access to resources Recommend Favorite

Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 11, 2015-11 ,pp. : 1154-1160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Platelets and Anticoagulant Capacity in Patients with Inflammatory Bowel Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 2, 2002-07 ,pp. : 92-96

Karger

Access to resources Recommend Favorite

Drug therapy: dose-response relationship of oral mesalazine in inflammatory bowel disease

By Mulder C. J. J.   Hazel S. J. Van Den  

Mediators of Inflammation, Vol. 7, Iss. 3, 1998-06 ,pp. : 135-136

Informa Healthcare

Access to resources Recommend Favorite